Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP217944.RAVp0GEKRRvNMRRc0cHYGq5kzFy78ruMZSA8BbsUH7JUo130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217944.RAVp0GEKRRvNMRRc0cHYGq5kzFy78ruMZSA8BbsUH7JUo130_provenance.
• NP221991.RAUuIrSS1kCWKcuEkIuVt19QJBAWB4QrpHNq1b4cwWbxc130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221991.RAUuIrSS1kCWKcuEkIuVt19QJBAWB4QrpHNq1b4cwWbxc130_provenance.
• NP645094.RAY3qSJy9CDmrkLe4IQuWO6NkbHXasrTrUTSjbeZP_iL0130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645094.RAY3qSJy9CDmrkLe4IQuWO6NkbHXasrTrUTSjbeZP_iL0130_provenance.
• NP645099.RAYJPUrt8sMoXK44M_g1Yx4YEk2APE_NLzsX28gKORSPQ130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645099.RAYJPUrt8sMoXK44M_g1Yx4YEk2APE_NLzsX28gKORSPQ130_provenance.
• NP221940.RABVyb5-zKI_9C1oHFe8QOGwutCLfRtiXUo5ELEswymZY130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221940.RABVyb5-zKI_9C1oHFe8QOGwutCLfRtiXUo5ELEswymZY130_provenance.
• assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP824220.RAt45ExpjtUyrR98Xs4lf9tfAjLqevAb_sdVBk2-nq5zQ130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824220.RAt45ExpjtUyrR98Xs4lf9tfAjLqevAb_sdVBk2-nq5zQ130_provenance.
• NP645096.RArHHBx3TNGUIzjbMdv_ip5PbPmrvlEkBVDvB10iCx0oM130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645096.RArHHBx3TNGUIzjbMdv_ip5PbPmrvlEkBVDvB10iCx0oM130_provenance.
• NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
• NP645100.RAs_46Cd4TVKXSP3nzEJNvC0_i1Urlc_ctcsIS6nxwEtQ130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645100.RAs_46Cd4TVKXSP3nzEJNvC0_i1Urlc_ctcsIS6nxwEtQ130_provenance.
• NP645102.RAtC7loLj-XMtwrVdZxmA-QJ8eXBsuO_L_n9ZxWQF_1sI130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645102.RAtC7loLj-XMtwrVdZxmA-QJ8eXBsuO_L_n9ZxWQF_1sI130_provenance.
• NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.
• NP645095.RAIcZ-vKcGApPcgBwzVS7VzMWSakeJ3M_pqNu9pCOUXLI130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645095.RAIcZ-vKcGApPcgBwzVS7VzMWSakeJ3M_pqNu9pCOUXLI130_provenance.
• NP986611.RA7nTcJGBRh7eKfPeb_wEcJRkbqRT-Q835ZKNLCo5LBNQ130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986611.RA7nTcJGBRh7eKfPeb_wEcJRkbqRT-Q835ZKNLCo5LBNQ130_provenance.
• NP990383.RAwodBraNBtktiFZYX0Ee9BnquAOkx86qAN79mEb2OLvA130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990383.RAwodBraNBtktiFZYX0Ee9BnquAOkx86qAN79mEb2OLvA130_provenance.
• NP1000926.RAx1SfFnlKt96GK8w-Tqk4D0edAozsTeq1cHvkjJ49rZ0130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000926.RAx1SfFnlKt96GK8w-Tqk4D0edAozsTeq1cHvkjJ49rZ0130_provenance.
• NP1004702.RA8BV4WUwO-hjEMoMe1bl7x3ZB_Mc-AFL7Se04ab8vOiM130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004702.RA8BV4WUwO-hjEMoMe1bl7x3ZB_Mc-AFL7Se04ab8vOiM130_provenance.
• NP645097.RA42nI142jr5LQI4qWIuqZc3TFmFPyA6jCnfDEt3WdcZI130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645097.RA42nI142jr5LQI4qWIuqZc3TFmFPyA6jCnfDEt3WdcZI130_provenance.
• NP645103.RA_41BPbXv06KxORECRVodmtgYMQfiomW2wwAV7bWhq94130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645103.RA_41BPbXv06KxORECRVodmtgYMQfiomW2wwAV7bWhq94130_provenance.